Physician profile
Sofia Thomas
NPI 1962064071
$1,387.36
in general payments reported to CMS, 2019-2025
12 companies · $263 in 2025
The $263 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $206 · 2022: $758 · 2023: $161 · 2025: $263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $423.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $262.90 | 2025 | Terlivaz |
| Vifor Pharma, INC. | $232.92 | 2022 | |
| Amgen INC. | $142.37 | 2021 | |
| Boston Scientific Corporation | $136.07 | 2023 | Watchman Access System |
| Alnylam Pharmaceuticals INC. | $117.77 | 2022 | |
| Esperion Therapeutics, INC. | $103.14 | 2022 | |
| Neurocrine Biosciences, INC. | $101.79 | 2022 | |
| Global Blood Therapeutics, INC. | $97.50 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $88.63 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $62.35 | 2021-2022 | |
| Novo Nordisk INC | $24.45 | 2023 | Ozempic |
| Janssen Pharmaceuticals, INC | $17.47 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sofia Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.